Roivant Sciences (ROIV) Price to Sales (2021 - 2026)
Roivant Sciences' Price to Sales was 3395.54 in fiscal Q1 2027 (quarter ended Jun 30, 2026), up 926.0% from 330.94 a year earlier and up 40.6% from the prior quarter.
Powered by 
Analysis
Roivant Sciences (ROIV) Price to Sales (2021 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Price to Sales at Roivant Sciences came in at 2415.71, up 899.5% from FY2025.
- In earlier fiscal years, Price to Sales was 241.70 in FY2025 (-7.0%), 259.91 in FY2024 (+46.1%), 177.92 in FY2023 (+186.5%) and 62.10 in FY2022 (-76.0%).
- The fiscal Q1 2027 figure marks the highest quarterly Price to Sales in data going back to fiscal Q4 2021.
- Compared with a year earlier, Price to Sales has increased for seven straight quarters, with growth averaging 297.0% over the last eight quarters.
- The best year-over-year quarter for Price to Sales over five years was fiscal Q1 2027 (growth of 926.0%); the worst was fiscal Q4 2022 (a decline of 76.0%).
- Per Business Quant data, ROIV's Price to Sales in the three fiscal quarters before Q1 2027 was 2415.71 (Q4 2026), 1157.04 (Q3 2026) and 513.31 (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Roivant Sciences | 25.81 Bn | 26.50 Bn | 1.16 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3,395.54 |
| Mar 31, 2026 | 2,415.71 |
| Dec 31, 2025 | 1,157.04 |
| Sep 30, 2025 | 513.31 |
| Jun 30, 2025 | 330.94 |
| Mar 31, 2025 | 241.70 |
| Dec 31, 2024 | 279.10 |
| Sep 30, 2024 | 228.43 |
| Jun 30, 2024 | 215.68 |
| Mar 31, 2024 | 170.55 |
| Dec 31, 2023 | 235.02 |
| Sep 30, 2023 | 234.12 |
| Jun 30, 2023 | 158.34 |
| Mar 31, 2023 | 177.92 |
| Dec 31, 2022 | 134.65 |
| Sep 30, 2022 | 44.99 |
| Jun 30, 2022 | 55.02 |
| Mar 31, 2022 | 62.10 |
| Dec 31, 2021 | 113.96 |
| Sep 30, 2021 | 150.24 |
API Access
Roivant Sciences Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=ROIV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "ROIV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=ROIV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();